The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma. - Kotch C; Gomes A; Schatz KS; Dombi E; Brown S; Gross AM; Alves M; Perreault S; Mueller S; Reddy AT; Romo C; Bornhorst M; et al. (Human genetics, 2025)